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Abstract 
Background: Mycoplasma is a genus of bacteria often found in the normal flora of the mouth, respiratory system 
and urogenital tract; but potentially pathogenic species also exist which can cause serious respiratory and genital 
diseases in human including postpartum fever, pelvic inflammatory infections, and pyelonephritis. The aim of this 
study was to evaluate the prevalence of Mycoplasma genitalium and Mycoplasma hominis in women who referred to 
the health centers in Karaj and investigate the susceptibility of M. genitalium strains against fluoroquinolone 
antibiotics. Materials and Methods: Endocervical swabs were taken from 200 women with cervicitis. Nucleic 
Acid Amplification Tests (NAATs) were performed for detecting Mgpa gene in M. genitalium and RNH gene in M. 
hominis. Mutations in parC and gyrA genes, as well as antibiotic resistance, were studied in positive samples of M. 
genitalium. Results: M. genitalium(n=9) and  M. hominis(n=11) positive samples were found among samples 
obtained from women with cervicitis. Positive samples of M.genitalium were examined for isolating the parC and 
gyrA genes. Six sequences of these genes were analyzed by MEGA5 software. Mutation in parC gene was observed 
in one sequence which %16 shows resistance. Conclusion: M. hominis and M. genitalium were detected in 5.5% and 
4.5% of samples, respectively. Our findings showed a relatively medium prevalence of M. hominis and M. 
genitalium in women with cervicitis in Alborz province. The sequencing results of gyrA and parC genes in this study 
represent the occurrence of mutations which drive fluoroquinolones resistance. Therefore, further studies in this field 
are needed in Iran and other countries, and to address the problems of increasing antibiotic-resistant strains, irregular 
administration and antibiotic susceptibility testing, more attention should be paid. 
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Sexually Transmitted Infections (STIs) are a 
common major public health problem. In some 
developing countries, STI is one of the five common 
diseases. The World Health Organization (WHO) 
appraises that within 340 million new cases of STIs 
occur yearly. (1, 2) Mollicutes are found in both 
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STIs and healthy individuals (1). This study is 
designed to expound the role of these bacteria in 
women with cervicitis. Since the polymerase chain 
reaction (PCR)-based assays more simplified 
detection of M. genitalium and M. hominis in 
clinical specimens; it has been shown that M. 
hominis is related with non-gonococcal urethritis 
(NGU), bacterial vaginosis (BV), post-birth fever, 
and rarely with arthritis, peritonitis, meningitis, and 
bacteremia. M. genitalium is highly associated with 
NGU in men and salpingitis, cervicitis, pelvic 
inflammatory and endometritis diseases in women 
(3- 5). Although limited clinical data are available 
regarding the treatment of M. genitalium 
infections, eradiation rate of M. genitalium with a 
single 1g dose of azithromycin was reported to be 
72–87% in most therapies. In the clinical range of 
M. genitalium, determining the antimicrobial 
resistance is critical for considering the treatment 
guidelines. The use of Mycoplasma culture method 
to evaluate antibiotic resistance is still a laborious 
and time-consuming process. Hence, in this study, 
we attempted to use a molecular procedure that not 
includes the isolation of M. genitalium and 
antimicrobial susceptibility testing in a laboratory 
to determine fluoroquinolone- resistance in 
bacterial clinical specimens. Fluoroquinolones act 
by binding to topoisomerase IV and DNA gyrase, 
which are target enzymes, and therefore interpose 
with DNA replication. DNA gyrase is composed of 
GyrA and GyrB each one two subunits, and 
topoisomerase IV consists of ParC and ParE each 
one two subunits. Alterations in GyrA subunit of 
DNA gyrase and/or the ParC subunit of 
topoisomerase IV in bacterial species are major 
mechanisms of fluoroquinolone resistance, 
including mycoplasmas and ureaplasmas. 
Alterations in GyrB and ParE play a 
complementary role in the increasing rates of 
fluoroquinolone resistance. Accordingly, in this 
study, we amplified the quinolone-resistance-
determining region (QRDR) of the gyrA gene and 
the analogous region of the parC gene from the 
DNA of M. genitalium extracted from endocervical 
swab samples of women with cervicitis and 
determined their sequences. Amino acid changes in 
GyrA and ParC caused by mutations in the QRDRs 
of the gyrA and parC genes were compared with 
those previously reported in fluoroquinolone 
resistant mutants of other Mycoplasma and 
Ureaplasma spp. (6-8). 
Methods 
Inclusion criteria. This analytical cross-
sectional study analyzed clinical samples collected 
from Karaj, capital of Alborz Province, Iran. The 
study group consisted of 201 women, aged 17 to 60 
years, and the average age of 35 years. Clinical 
samples were collected (Endocervical swab). 
Questions were asked from each of the women with 
cervicitis and the relevant questionnaire was 
completed. Pregnant women were not studied in our 
study. Clinical symptoms, such as inflammation, 
itch, discharge and stench were considered as well as 
the case background including addiction, 
antimicrobial therapy over the last month, having 
abortions, number of abortions and infertility. 
Clinical sample. The samples were collected 
from Sep 2015 to Aug of 2016. The swabs were 
rubbed on the endocervical surface. The samples 
were stored at 4°C in 7 mL of 2Sp medium transport 
media. DNA extraction was performed on cervical 
samples and stored at −20°C for qPCR. 
DNA extraction and PCR amplification. 
Genomic DNA samples of cervical swabs were 
obtained in accordance with QIAamp DNA Mini 
Kit. Quantitative-PCR was used for detection of 
genital Mycoplasmas. The primers used for the 
detection of  M. hominis were as follows: RNAH 
forward primer sequence: RNH1: 5´-
CAATGGCTAATGCCGGATACGC-3' and reverse 
primer sequence: RNH2: 5´-
GGTACCGTCAGTCTGCAAT-3' (6). In addition, 
primers for the detection of  M. genitalium  were: 
Mgpa forward primer sequence: Mgpa1: 5´-
AGTTGATGAAA CCTTAACCCCTTG-3 and 
reverse primer sequence: Mgpa3: Reverse5´- 
CATTACCAGTTA AACCAAAGCCT -3´ (7). PCR 
reaction was performed using Master Mix (0.3 μl 
dNTPs +2.5 μl buffer PCR + 0.5 μl MgCl2 + 16 μl 
DW + 0.5 μl primer forward + 0.5 μl primer reverse 
+ 0.2 μl Taq polymerase) +5 μl DNA template in a 
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total volume of 25μl. The PCR reaction was 
performed according to the following program: 
pre-denaturation for 5 minutes at 95ºC followed by 
30 cycles of denaturation at 94ºC for 30 seconds, 
annealing for 30 seconds (at 57ºC for M. hominis 
and 56ºC for M. genitalium) and extension at 72ºC 
for 60 seconds. The last cycle was followed by an 
extra extension step at 72ºC for 5 minutes. The M. 
genitalium (ATCC: 33530) and M. hominis 
(ATCC: 15056)  extracted DNA, as well as sterile 
double-distilled water,  were used as positive and 
negative controls for PCR reaction, respectively. 
PCR products were electrophoresed on 1% agarose 
gel, and stained with Gel red (CinaGen Co, Tehran, 
and Iran) and visualized under a UV Tran 
illuminator. 
Determination of the quinolone resistance 
determining regions of the gyrA and parC genes 
in Mycoplasma genitalium. From these DNA 
samples, segment of the parC gene and analogous 
region of the gyrA gene in M. genitalium were 




3ʹ) were used, and PCR primers for the parC gene 
were MG-PARC-A (5ʹ-TGGGCTTA 
AAACCCACCACT-3ʹ) and MG-PARC-B (5ʹ-
CGGGTTTCTGTGTAACGCAT-3ʹ).PCR products 
were re-amplified using the same primer pair and 
the purified PCR products were sequenced  (4). 
Comparison of amino acid alterations in 
gyrA and parC with those associated with 
Fluoroquinolone resistance. In this study 
mutations in the QRDRs of the gyrA and parC 
genes were compared with other reported 
previously in fluoroquinolone-resistant mutants of 
others Mycoplasma and Ureaplasma spp. 
Statistical analysis. Frequencies of infections 
were described with numbers and percent within 
95% confidence interval. Collected clinical and 
epidemiological information were analyzed using 
the SPSS 24.0 software. Chi-square and Fisher’s 
exact test were conducted to determine the 
relationship between variables. P-value less than 
0.05 were considered as statistically significant. 
Results 
M. hominis and M. genitalium were detected 
in 5.5% and 4.5% of samples, respectively. Co-
infection was detected with M. genitalium and M. 
hominis in two cases (0.9%). The M. hominis and  M 
genitalium detected by qPCR, showed that women 
aged 36 to 45 years have more contamination with 
M. hominis and women aged 26 to 35 years have 
more contamination to M. genitalium but there is no 
significant difference between different age in tow 
groups (P=0.59, P=0.92) (see table2). Other 
parameters such as educational level, occupation, 
contraceptive method, and abortion history and 
infertility status were studied and there are no 
significant difference among different groups (see 
table2).  G→T transition at nucleotide position 259 
(Asp-87→Tyr) was detected in parC gene in one 
sample. No mutations were found in gyrA genes, 
thus there was no amino acid change in GyrA and 
ParC in the residual 5 specimens. To our training, 
the Asp-87→Tyr mutation in ParC, was comparable 
to changes at amino acid situation 84 in E. coli ParC, 
was generally apperceive in fluoroquinolone-
resistant mutants of other Mycoplasma and 
Ureaplasma spp.   
 
Table1: PCR method for the detection of Mycoplasma genitalium and Mycoplasma hominis. 
PCR Results Positive Percent(95% CI) 
M. genitalium 9 4.5 (4.21- 4.79) 
M. hominis 11 5.5 (5.2-5.82) 
M. genitalium + M. hominis 2 0.9 (0.77-1.03) 
Total positive patients 18 8.99 (8.49-9.31) 
Total 201 100 
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Figure 5.  study of amino acid mutations in gyrA by MEGA5 software 
 
 
Figure 1. Agarose gel electrophoresis of Mycoplasma 
hominis. L: DNA size marker (100 bp DNA ladder) 2: 
positive control for  M. genitalium  3: negative control, 
4-12: positive samples. 
 
Figure 2. Agarose gel electrophoresis of Mycoplasma 
genitalium. L: DNA size marker (100 bp DNA ladder) 
2: negative control 3: positive control for M. 
genitalium, 4-7: positive samples. 
 
 
Figure 3. Agarose gel electrophoresis of gyrA gene. L: 
DNA size marker (100 bp DNA ladder) 2: negative 




Figure 4. Agarose gel electrophoresis of parC gene. 
L:DNA size marker (100 bp DNA ladder) 2: negative 




Figure 6.  study of amino acid mutations in parC by MEGA5 software mutation in the parC gene at nucleotide position 259 (Asp-
87→Tyr) was observed. 
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  N(%) N(%) N(%) 
0.59 0.92 
Ages (years) 
<25 years old 30(14.9%) 2(18.1%) 1(11.1%) 
26-35 years old 74(36.8%) 2(18.1%) 4(44.4%) 
36-45 years old 64(31.8%) 5(45.4%) 3(33.3%) 
>45 years old 33(16.4%) 2(18.1%) 1(11.1%) 
Level of 
education 
Illiterate 30(14.9%) 1(9%) 2(22.2%) 
0.56 0.84 
low – literate 70(34.8%) 6(54.5%) 2(22.2%) 
Diploma 79(39.3%) 3(27.2%) 4(44.4%) 
Higher education 22(10.9%) 1(9%) 1(11.1%) 
job 
Housewife 176(87.6%) 11(100%) 9(100%) 
0.22 0.29 
Employee 25(12.4%) 0(0%) 0(0%) 
History of 
Abortion 
Abortion 53(26.4%) 3(27.2%) 1(11.1%) 
0.5 0.2 
No Abortion 148(73.6%) 8(72.7%) 8(88.8%) 
History of 
infertility 
Infertility 26(12.9%) 1(9%) 2(22.2%) 
0.5 0.3 
No infertility 175(87.1) 10(90.9%) 7(77.7%) 
Contraceptio
n method 
No method 15(7.4%) 1(9%) 1(11.1%) 
0.76 0.94 
Condom 35(17.4%) 1(9%) 1(11.1%) 
Birth control pills 130(64.6%) 7(63.6%) 6(66.6%) 
IUD 21(10.4%) 2(18.1%) 1(11.1%) 
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Mycoplasmas are causative agents of 
sexually transmitted diseases. Many studies have 
been conducted to realize the distribution and 
epidemiology of mycoplasma in Iran. Several 
studies have reported different outbreaks of 
mycoplasma in different parts of the world. Studies 
on women in different countries show a high 
prevalence of Mycoplasma hominis; Turkey 5%, 
Brazil 38.5%, Denmark 6.6%, and Italy 3.6% (8, 
10-12). Worldwide studies have also been 
conducted to evaluate the frequency of 
Mycoplasma genitalium, including 98% in 
Denmark, 12.6% in Japan, 3.3% in the United 
Kingdom and 38% in France (11, 13- 15). In the 
present study, the prevalence of Mycoplasma 
genitalium and mycoplasma hominis was 4.5% and 
5.5%, respectively.  Several factors including the 
study population (receiving antibiotics, suffering 
from a genital infection, having multiple sexual 
partners, etc. number of samples, sampling method, 
age of the patients, culture, geographical area and 
the test method can justify the difference in 
prevalence. Is there a connection between 
symptoms of cervicitis and presence of M. 
genitalium? A link has been found between signs 
of cervicitis and M. genitalium in the United States, 
Japan, Sweden, and West Africa. Some causes of 
urethritis such as C. trachomatis and N. 
gonorrhoeae can cause cervical infection in 
women, but some women with cervicitis were not 
infected with these pathogens. Unlike our study, a 
study conducted in France on women with a 
vaginal discharge there was no relation between 
cervicitis and M. genitalium. Our findings suggest 
that, perhaps in women who have cervicitis as a 
consequence of its modest pathogenicity, the signs 
of cervicitis induced by M. genitalium are difficult 
to elicit (9). In the study ahead, change in amino 
acid sequence was found in ParC in M. genitalium 
isolated from the endocervical swab samples of 
women with cervicitis. This change of amino acid 
(Asp-87 → Tyr) in ParC was consistent with the 
change of amino acid position of 84 in ParC in E. 
coli, which it is suggested to be associated with 
resistance to other bacterial species, covering other 
mycoplasmas and ureaplasmas, such as 
fluoroquinolone resistance in M. genitalium. 
Nonetheless, the findings of this study showed that 1 
(16%) of 6 M. genitalium present in the endocervical 
swab samples of women with cervicitis underwent a 
mutation leading to the decreased susceptibility to 
fluoroquinolones. For the treatment of urogenital 
infections, fluoroquinolones were most often used. 
Mutants with reduced susceptibility to 
fluoroquinolones of M. genitalium could have been 
selected in clinical practice is not known how the 
emergence of clinical polymorphisms of M. 
genitalium Containing changes such as amino acid 
changes in ParC in the present study can threaten the 
effectiveness of treatment of M. genitalium 
infections by fluoroquinolones. However, attainment 
of  an amino acid change only in GyrA or ParC may 
be the first step in creating significant resistance to 
fluoroquinolones. Eventually, Aggregation of amino 
acid changes in GyrA and ParC could be induced by 
serial exposure of strains with a single amino acid 
change in GyrA or ParC to fluoroquinolones and 
could bring about the increase in the level of 
fluoroquinolone resistance. Fluoroquinolone 
resistance due to the emergence of M. genitalium 
with ParC alterations could be a disturbing issue. To 
prevent such resistances, antimicrobial resistance 
monitoring of M. genitalium is necessary to detect 
antimicrobial resistance and appropriate prevention 
However, in the case of M. genitalium infections, a 
serious barrier to controlling drug resistance is the 
difficulty of routine cultivation of this bacterium 
from clinical specimens. Therefore, molecular 
assays for non-culture specimens will be needed to 
monitor molecular markers associated with 
antimicrobial resistance in clinical strains of M. 
genitalium, as shown in the present study. In 
conclusion, amino acid alterations in ParC of M. 
genitalium analogous to those observed commonly 
in fluoroquinolone resistant mutants of other 
Mycoplasma and Ureaplasma spp. were observed in 
1 (16%) of 6 M. genitalium found in the 
endocervical swab samples of women with  
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cervicitis. We know that the limitations of this 
study include absence of analyze of other 
mechanisms of fluoroquinolone resistance, such as 
mutations in the GyrB and ParE genes and changes 
in drug penetration and drug efflux, as well as a 
small number of samples examined. Nevertheless, 
the findings show that clinical strains of M. 
genitalium with diminished susceptibility to 
fluoroquinolones may  appear. In addition, the non-
culture method used in this study is useful for 
evaluating the antimicrobial resistance of clinical 
isolates of M. genitalium when mycoplasma culture 
and antimicrobial susceptibility testing from 
clinical specimens in laboratory experiments is not 
performed (4, 16). 
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